Literature DB >> 11583916

Evidence for involvement of c-Src in the anti-apoptotic action of nitric oxide in serum-deprived RINm5F cells.

J R Tejedo1, R Ramírez, G M Cahuana, P Rincón, F Sobrino, F J Bedoya.   

Abstract

The mechanism by which nitric oxide (NO) protects from apoptosis is a matter of debate. We have shown previously that phosphorylation of tyrosine residues participates in the protection from apoptosis in insulin-producing RINm5F cells (Inorg. Chem. Commun. 3 (2000) 32). Since NO has been reported to activate the tyrosine kinase c-Src and this kinase is involved in the activation of protein kinase G (PKG) in some cell systems, we aimed at studying the contribution of c-Src and PKG systems in anti-apoptotic actions of NO in serum-deprived RINm5F cells. Here we report that exposure of serum-deprived cells to 10 microM DETA/NO results in protection from degradation of the anti-apoptotic protein Bcl-2, together with a reduction of cytochrome c release from mitochondria and caspase-3 inhibition. Studies with the inhibitors ODQ and KT-5823 revealed that these actions are dependent on both activation of guanylate cyclase and PKG. DETA/NO was also able to induce autophosphorylation and activation c-Src protein both in vivo and in vitro and active c-Src was able to induce tyrosine phosphorylation of Bcl-2 in vitro. The c-Src kinase inhibitor PP1 abrogated the actions of DETA/NO on cGMP formation, PKG activation, caspase activation, cytochrome c release from mitochondria, and Bcl-2 phosphorylation and degradation in serum-deprived cells. We thus propose that activation of c-Src is an early step in the chain of events that signal cGMP-dependent anti-apoptotic actions of NO in mitocohondria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583916     DOI: 10.1016/s0898-6568(01)00206-6

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  Regulation of L-type CaV1.3 channel activity and insulin secretion by the cGMP-PKG signaling pathway.

Authors:  Alejandro Sandoval; Paz Duran; María A Gandini; Arturo Andrade; Angélica Almanza; Simon Kaja; Ricardo Felix
Journal:  Cell Calcium       Date:  2017-05-15       Impact factor: 6.817

2.  Impact of exposure to low concentrations of nitric oxide on protein profile in murine and human pancreatic islet cells.

Authors:  Rafael Tapia-Limonchi; Irene Díaz; Gladys M Cahuana; Mario Bautista; Franz Martín; Bernat Soria; Juan R Tejedo; Francisco J Bedoya
Journal:  Islets       Date:  2014       Impact factor: 2.694

3.  Src activation generates reactive oxygen species and impairs metabolism-secretion coupling in diabetic Goto-Kakizaki and ouabain-treated rat pancreatic islets.

Authors:  R Kominato; S Fujimoto; E Mukai; Y Nakamura; K Nabe; M Shimodahira; Y Nishi; S Funakoshi; Y Seino; N Inagaki
Journal:  Diabetologia       Date:  2008-05-01       Impact factor: 10.122

Review 4.  Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation.

Authors:  Sangbin Lim; Kelly R Smith; Ssang-Taek Steve Lim; Rong Tian; Jianrong Lu; Ming Tan
Journal:  Cell Biosci       Date:  2016-04-14       Impact factor: 7.133

5.  Nitric oxide prevents H2O2-induced apoptosis in SK-N-MC human neuroblastoma cells.

Authors:  Yeong-Min Yoo; Eui-Man Jung; Changhwan Ahn; Eui-Bae Jeung
Journal:  Int J Biol Sci       Date:  2018-11-02       Impact factor: 6.580

6.  Nitric oxide is a mediator of antiproliferative effects induced by proinflammatory cytokines on pancreatic beta cells.

Authors:  Laura Quintana-Lopez; Manuel Blandino-Rosano; Gonzalo Perez-Arana; Alberto Cebada-Aleu; Alfonso Lechuga-Sancho; Manuel Aguilar-Diosdado; Carmen Segundo
Journal:  Mediators Inflamm       Date:  2013-06-12       Impact factor: 4.711

7.  Effect of oral nitrite administration on gene expression of SNARE proteins involved in insulin secretion from pancreatic islets of male type 2 diabetic rats.

Authors:  Asghar Ghasemi; Hamideh Afzali; Sajad Jeddi
Journal:  Biomed J       Date:  2021-04-20       Impact factor: 7.892

8.  Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.

Authors:  E L Leung; M Fraser; R R Fiscus; B K Tsang
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

9.  Enhanced MIN-6 beta cell survival and function on a nitric oxide-releasing peptide amphiphile nanomatrix.

Authors:  Dong-Jin Lim; Adinarayana Andukuri; Jeremy B Vines; Shibli M Rahman; Patrick Tj Hwang; Jeonga Kim; Anath Shalev; John A Corbett; Ho-Wook Jun
Journal:  Int J Nanomedicine       Date:  2014-05-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.